GZR4 clinical trials
How each study uses GZR4 is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the GZR4 studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Name
- GZR4
- 7
Studies by the year they started
7 studies that test it; most in 2025 (4)
| Year | Studies |
|---|---|
| 2022 | 1 |
| 2023 | 1 |
| 2024 | 1 |
| 2025 | 4 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 7 · Other 0
Gan & Lee Pharmaceuticals. (4) · Gan and Lee Pharmaceuticals, USA (3)
Coming up
From the study records. Dates are the sponsors’ own estimates and often move.
Reaching primary completion within a year · 1, 1 in phase 3
Studies that test GZR4, phase 3 first.
- Nov 2026A Phase IIIb Clinical Study to Assess the Efficacy and Safety of GZR4 in Subjects With Type 2 Diabetes Mellitus Treated With Basal InsulinPhase 3 · Gan & Lee Pharmaceuticals.
Studies
Open first, then newest update. How each study uses GZR4 is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 7
- A Phase IIIb Clinical Study to Assess the Efficacy and Safety of GZR4 in Subjects With Type 2 Diabetes Mellitus Treated With Basal InsulinRecruitingPhase 3Gan & Lee Pharmaceuticals.NCT07165223Written as GZR4
- A Phase III Clinical Study to Assess the Efficacy and Safety of GZR4 in Insulin-naive Subjects With Type 2 Diabetes Mellitus (T2DM)Active, not recruitingPhase 3Gan & Lee Pharmaceuticals.NCT06767735Written as GZR4
- Pharmacokinetic and Safety Study of GZR4 Injection in Subjects With Hepatic ImpairmentActive, not recruitingPhase 1Gan & Lee Pharmaceuticals.NCT07193147Written as GZR4
- A Phase III Clinical Study to Assess the Efficacy and Safety of GZR4 in Type 2 Diabetes Mellitus Subjects (T2DM) Treated With Basal + Prandial InsulinActive, not recruitingPhase 3Gan & Lee Pharmaceuticals.NCT06767761Written as GZR4
- Pharmacokinetics and Safety Profile of a Single Dose GZR4 in Subjects with Renal ImpairmentCompletedPhase 1Gan and Lee Pharmaceuticals, USANCT06547502Written as GZR4
- A Trial Investigating the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GZR4 in Subjects With Type 2 DiabetesCompletedPhase 1Gan and Lee Pharmaceuticals, USANCT06553248Written as GZR4
- Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single-dose GZR4CompletedPhase 1Gan and Lee Pharmaceuticals, USANCT06548815Written as GZR4